287 related articles for article (PubMed ID: 33948353)
1. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways.
Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L
Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353
[TBL] [Abstract][Full Text] [Related]
2. The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma.
Tang J; Peng S; Yan H; Ni M; Hou X; Ma P; Li Y
Transl Oncol; 2022 Aug; 22():101463. PubMed ID: 35691247
[TBL] [Abstract][Full Text] [Related]
3. A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia.
Hao X; Gu M; Sun J; Cong L
J Clin Lab Anal; 2020 Feb; 34(2):e23052. PubMed ID: 31617252
[TBL] [Abstract][Full Text] [Related]
4. Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer patients.
Wan X; Hong Z; Mao Y; Di W
Transl Cancer Res; 2020 Feb; 9(2):726-734. PubMed ID: 35117418
[TBL] [Abstract][Full Text] [Related]
5. A-Kinase Interacting Protein 1 Knockdown Restores Chemosensitivity
Zheng H; Lin Q; Rao Y
Front Oncol; 2022; 12():854702. PubMed ID: 35965570
[TBL] [Abstract][Full Text] [Related]
6. AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells.
Zhang W; Wu Q; Wang C; Yang L; Liu P; Ma C
Mol Cell Biochem; 2018 Nov; 448(1-2):311-320. PubMed ID: 29520695
[TBL] [Abstract][Full Text] [Related]
7. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
8. A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer.
Wang D; Luo Y; Guo Y; Li G; Li F
Int J Biol Markers; 2020 Jun; 35(2):74-81. PubMed ID: 32339056
[TBL] [Abstract][Full Text] [Related]
9. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
[TBL] [Abstract][Full Text] [Related]
10. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients.
Gu L; Yao Y; Chen Z
Transl Cancer Res; 2021 Feb; 10(2):748-758. PubMed ID: 35116406
[TBL] [Abstract][Full Text] [Related]
11. GDNF triggers proliferation of rat C6 glioma cells via the NF-κB/CXCL1 signaling pathway.
Wang Y; Wu Y; Li L; Gao J; Gao DS; Sun S
PLoS One; 2023; 18(8):e0289071. PubMed ID: 37594930
[TBL] [Abstract][Full Text] [Related]
12. CXCL8 gene silencing promotes neuroglial cells activation while inhibiting neuroinflammation through the PI3K/Akt/NF-κB-signaling pathway in mice with ischemic stroke.
Lv H; Li J; Che YQ
J Cell Physiol; 2019 May; 234(5):7341-7355. PubMed ID: 30362547
[TBL] [Abstract][Full Text] [Related]
13. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
Wan S; Liu C; Li C; Wang Z; Zhao G; Li J; Ran W; Zhong X; Li Y; Zhang L; Cui H
Oncogene; 2023 Sep; 42(39):2905-2918. PubMed ID: 37596322
[TBL] [Abstract][Full Text] [Related]
14. A-Kinase Interacting Protein 1 Promotes Cell Invasion and Stemness
Luo Z; Luo Y; Xiao K
Front Oncol; 2021; 11():798557. PubMed ID: 35355804
[TBL] [Abstract][Full Text] [Related]
15. Small GTPase RHOE/RND3, a new critical regulator of NF-κB signalling in glioblastoma multiforme?
Sun Q; Dong H; Li Y; Yuan F; Xu Y; Mao S; Xiong X; Chen Q; Liu B
Cell Prolif; 2019 Sep; 52(5):e12665. PubMed ID: 31332862
[TBL] [Abstract][Full Text] [Related]
16. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
Chen H; Yan S; Dong L; Li X
J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
18. AKIP1 promotes tumor progression by cancer-related pathways and predicts prognosis in tongue squamous cell carcinoma.
Wang N; Bai D; Kristiansen E; Deng R; Zhang S
Am J Transl Res; 2021; 13(11):12338-12351. PubMed ID: 34956456
[TBL] [Abstract][Full Text] [Related]
19. AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65.
Gao N; Asamitsu K; Hibi Y; Ueno T; Okamoto T
J Biol Chem; 2008 Mar; 283(12):7834-43. PubMed ID: 18178962
[TBL] [Abstract][Full Text] [Related]
20. A-kinase interacting protein 1 regulates the cell proliferation, invasion, migration and angiogenesis of clear cell renal cell carcinoma cells and affects the ERK/c-Myc signaling pathway by binding to Rac1.
Zhang Y; Zhang H; Han Z; Wang X; Li X; Yuan P; Ji S; Liu Q
Exp Ther Med; 2022 Sep; 24(3):558. PubMed ID: 35978938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
